Company
Virbac SA
Headquarters: Carros, France
Employees: 4,907
CEO: Mr. Habib Ramdani
Market Cap
€3.08 Billion
EUR as of April 1, 2022
US$3.40 Billion
France
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
Johnson & Johnson
|
$475.93 B |
Roche
|
$349.50 B |
|
Pfizer
|
$300.79 B |
|
AbbVie
|
$294.27 B |
|
Lilly
|
$273.01 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$488.52 B |
|
Johnson & Johnson
|
$475.93 B |
|
Roche
|
$349.50 B |
|
Pfizer
|
$300.79 B |
|
AbbVie
|
$294.27 B |
Detailed Description
Virbac SA manufactures and sells pharmaceutical, biological, nutritional, and diagnostic products for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, and the Middle East and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Stocks & Indices
Virbac SA has the following listings and related stock indices.
Stock: Euronext: VIRP
Stock: FSX: V16
Stock: OTC: VRBCF